These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30615804)

  • 21. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.
    Tetzloff KA; Graff-Radford J; Martin PR; Tosakulwong N; Machulda MM; Duffy JR; Clark HM; Senjem ML; Schwarz CG; Spychalla AJ; Drubach DA; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    J Alzheimers Dis; 2018; 62(4):1713-1724. PubMed ID: 29614676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
    van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
    Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Smith R; Schöll M; Londos E; Ohlsson T; Hansson O
    Sci Rep; 2018 Mar; 8(1):4717. PubMed ID: 29549278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between tau PET and retrospective cortical thinning in clinically normal elderly.
    LaPoint MR; Chhatwal JP; Sepulcre J; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2017 Aug; 157():612-622. PubMed ID: 28545932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau in dementia with Lewy bodies.
    Chin KS; Churilov L; Doré V; Villemagne VL; Rowe CC; Yassi N; Watson R
    Aust N Z J Psychiatry; 2024 Feb; 58(2):175-182. PubMed ID: 37264610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia.
    Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Aust N Z J Psychiatry; 2020 Jun; 54(6):633-643. PubMed ID: 31696728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome.
    Goodheart AE; Locascio JJ; Samore WR; Collins JA; Brickhouse M; Schultz A; Touroutoglou A; Johnson KA; Frosch MP; Growdon JH; Dickerson BC; Gomperts SN
    Brain; 2021 Feb; 144(1):266-277. PubMed ID: 33578418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.
    Oppedal K; Ferreira D; Cavallin L; Lemstra AW; Ten Kate M; Padovani A; Rektorova I; Bonanni L; Wahlund LO; Engedal K; Nobili F; Kramberger M; Taylor JP; Hort J; Snædal J; Blanc F; Walker Z; Antonini A; Westman E; Aarsland D;
    Alzheimers Dement; 2019 Mar; 15(3):400-409. PubMed ID: 30439333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ;
    Brain; 2023 Nov; 146(11):4520-4531. PubMed ID: 37284793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies.
    Huang SH; Chang CC; Lui CC; Chen NC; Lee CC; Wang PW; Jiang CF
    Clin Nucl Med; 2015 Jan; 40(1):26-31. PubMed ID: 25426755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.
    Graff-Radford J; Boeve BF; Pedraza O; Ferman TJ; Przybelski S; Lesnick TG; Vemuri P; Senjem ML; Smith GE; Knopman DS; Lowe V; Jack CR; Petersen RC; Kantarci K
    Brain; 2012 Aug; 135(Pt 8):2470-7. PubMed ID: 22810436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration.
    Kantarci K; Nedelska Z; Chen Q; Senjem ML; Schwarz CG; Gunter JL; Przybelski SA; Lesnick TG; Kremers WK; Fields JA; Graff-Radford J; Savica R; Jones D; Botha H; Knopman DS; Lowe V; Graff-Radford NR; Murray MM; Dickson DW; Reichard RR; Jack CR; Petersen RC; Ferman TJ; Boeve BF
    Brain Commun; 2022; 4(2):fcac013. PubMed ID: 35415608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
    Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.
    Nedelska Z; Schwarz CG; Boeve BF; Lowe VJ; Reid RI; Przybelski SA; Lesnick TG; Gunter JL; Senjem ML; Ferman TJ; Smith GE; Geda YE; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neurobiol Aging; 2015 Jun; 36(6):2010-7. PubMed ID: 25863527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.